Capture.PNG
Silence Therapeutics Achieves Another Research Milestone Payment from Mallinckrodt Collaboration for Complement-Mediated Diseases
April 28, 2021 07:00 ET | Silence Therapeutics plc
Silence Therapeutics Achieves Another Research Milestone Payment from Mallinckrodt Collaboration for Complement-Mediated Diseases 28 April 2021 LONDON, Silence Therapeutics plc, AIM: SLN and Nasdaq:...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mallinckrodt, Oasmia Pharmaceutical, Aclaris Therapeutics, and Carbonite and Encourages Investors to Contact the Firm
September 03, 2019 22:30 ET | Bragar Eagel & Squire
NEW YORK, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Mallinckrodt Plc (NYSE:...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Karyopharm, L Brands, National General, and Mallinckrodt and Encourages Investors to Contact the Firm
August 27, 2019 08:00 ET | Bragar Eagel & Squire
NEW YORK, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Karyopharm Therapeutics,...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mallinckrodt, Oasmia Pharmaceutical, Aclaris Therapeutics, and Curaleaf and Encourages Investors to Contact the Firm
August 18, 2019 19:30 ET | Bragar Eagel & Squire
NEW YORK, Aug. 18, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Mallinckrodt Plc (NYSE:...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against L Brands, National General, Mallinckrodt, and Oasmia and Encourages Investors to Contact the Firm
August 11, 2019 19:17 ET | Bragar Eagel & Squire
NEW YORK, Aug. 11, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of L brands, Inc. (NYSE: LB),...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mallinckrodt, Oasmia Pharmaceutical, 3M Company, and Aclaris Therapeutics and Encourages Investors to Contact the Firm
August 05, 2019 21:30 ET | Bragar Eagel & Squire
NEW YORK, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Mallinckrodt Plc, Oasmia...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Mallinckrodt Plc (NYSE: MNK) and Encourages Mallinckrodt Investors to Contact the Firm
July 29, 2019 21:30 ET | Bragar Eagel & Squire
NEW YORK, July 29, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. is Investigating Mallinckrodt plc (MNK) on Behalf of Stockholders and Encourages MNK Investors to Contact the Firm
May 01, 2019 21:00 ET | Bragar Eagel & Squire
NEW YORK, May 01, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Mallinckrodt plc (NYSE: MNK).  Our investigation concerns whether Mallinckrodt...
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Mallinckrodt Public Limited Company – MNK
February 20, 2017 15:59 ET | The Rosen Law Firm PA
NEW YORK, Feb. 20, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Mallinckrodt Public Limited...